Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tunable control of B. infantis abundance and gut metabolites by co-administration of human milk oligosaccharides

18 Jan 2024

Abstract excerpt

Precision engineering of the gut microbiome holds promise as an effective therapeutic approach for diseases associated with a disruption in this microbial community. Engrafting a live biotherapeutic product (LBP) in a predictable, controllable manner is key to the consistent success of this approach and has remained a challenge for most LBPs under development. We recently demonstrated high-level engraftment of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Infant Nutrition and Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38235736
DOI: 10.1080/19490976.2024.2304160

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tunable control of B. infantis abundance and gut metabolites by co-administration of human milk oligosaccharidesPMID 38235736Read ↗

Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiomeSemantic proximity Read ↗

A bifidobacterial enzyme orchestrates ecology and function of infant gut bacterial communitySemantic proximity Read ↗

Ecological Engineering of the Human Gut Microbiome: A Review and Testable Framework for Next-Generation TherapeuticsSemantic proximity Read ↗

Mother Knows Best: Deciphering the Antibacterial Properties of Human Milk OligosaccharidesSemantic proximity Read ↗

Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyondSemantic proximity Read ↗

Human milk oligosaccharides and infant gut bifidobacteria: Molecular strategies for their utilizationSemantic proximity Read ↗

Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiotaSemantic proximity Read ↗

Effects of Human Milk Oligosaccharides in Infant Health Based on Gut Microbiota AlterationSemantic proximity Read ↗

Co-Biotics - Dual Modulation of the Host and the MicrobiotaSemantic proximity Read ↗

Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem.Semantic proximity Read ↗

Human Milk Glycomics and Gut Microbial Genomics in Infant Feces Show a Correlation between Human Milk Oligosaccharides and Gut Microbiota: A Proof-of-Concept StudySemantic proximity Read ↗

Genomic analysis of cultivated infant microbiomes identifies <i>Bifidobacterium</i> 2’-fucosyllactose utilization can be facilitated by co-existing speciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.